免疫学-话题@MedSci

#免疫学#

70篇内容 | 3760人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1889439, encodeId=cdff1889439ff, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Nature Cancer: 肿瘤治疗加重COVID-19病情？——总结疫情下的肿瘤免疫学挑战, objectType=article, longId=202295, objectId=d22d2022951d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d22d2022951d, replyNumber=0, likeNumber=90, createdTime=2021-05-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d22d2022951d, moduleTitle=Nature Cancer: 肿瘤治疗加重COVID-19病情？——总结疫情下的肿瘤免疫学挑战, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d22d2022951d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889444, encodeId=5ebb18894445b, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=免疫学 FRONT CELL INFECT MI 期刊投稿经验, objectType=article, longId=211365, objectId=2da42113652d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da42113652d, replyNumber=0, likeNumber=86, createdTime=2021-08-15, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da42113652d, moduleTitle=免疫学 FRONT CELL INFECT MI 期刊投稿经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da42113652d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889437, encodeId=1179188943e4f, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究 , objectType=article, longId=200504, objectId=f82c200504b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f82c200504b9, replyNumber=0, likeNumber=115, createdTime=2021-01-29, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f82c200504b9, moduleTitle=CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f82c200504b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889433, encodeId=0657188943324, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=打造免疫学细胞研究”全链条”，推动“流式平台”与“单细胞平台”高效对接, objectType=article, longId=199019, objectId=581619901989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=581619901989, replyNumber=0, likeNumber=0, createdTime=2021-05-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=581619901989, moduleTitle=打造免疫学细胞研究”全链条”，推动“流式平台”与“单细胞平台”高效对接, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=581619901989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889431, encodeId=65881889431d6, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=免疫学靶点在新冠病毒治疗中的研究进展综述, objectType=article, longId=190869, objectId=76041908691a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76041908691a, replyNumber=0, likeNumber=84, createdTime=2020-07-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76041908691a, moduleTitle=免疫学靶点在新冠病毒治疗中的研究进展综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76041908691a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889436, encodeId=ff011889436c8, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Nature：COVID-19的性别差异具有免疫学基础, objectType=article, longId=200263, objectId=091d20026391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=091d20026391, replyNumber=0, likeNumber=109, createdTime=2021-04-10, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=091d20026391, moduleTitle=Nature：COVID-19的性别差异具有免疫学基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=091d20026391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889438, encodeId=ddb618894384c, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=J Periodontal Res：Tregs参与了牙周炎的骨免疫学机制，有利于临床治疗决策的制定, objectType=article, longId=201615, objectId=601f201615f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=601f201615f3, replyNumber=0, likeNumber=100, createdTime=2020-10-25, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=601f201615f3, moduleTitle=J Periodontal Res：Tregs参与了牙周炎的骨免疫学机制，有利于临床治疗决策的制定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=601f201615f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889432, encodeId=da8d18894324e, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=中国免疫学会理事长：病例锐减，新冠疫苗临床试验或移海外, objectType=article, longId=191589, objectId=4964191589d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4964191589d9, replyNumber=0, likeNumber=101, createdTime=2020-12-13, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4964191589d9, moduleTitle=中国免疫学会理事长：病例锐减，新冠疫苗临床试验或移海外, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4964191589d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889429, encodeId=f6a718894296a, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=J Rheumatol：原发性干燥综合征外周神经系统受累的神经生理学特征和免疫学特征, objectType=article, longId=189087, objectId=8ef118908eee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ef118908eee, replyNumber=0, likeNumber=135, createdTime=2020-04-07, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ef118908eee, moduleTitle=J Rheumatol：原发性干燥综合征外周神经系统受累的神经生理学特征和免疫学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ef118908eee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889426, encodeId=7483188942615, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=赛诺菲宣布将以25亿美元收购Synthorx，以增强其肿瘤免疫学业务, objectType=article, longId=184846, objectId=4182184846dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4182184846dc, replyNumber=0, likeNumber=0, createdTime=2020-09-02, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4182184846dc, moduleTitle=赛诺菲宣布将以25亿美元收购Synthorx，以增强其肿瘤免疫学业务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4182184846dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889435, encodeId=6cb6188943503, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=著名免疫学家董晨院士加盟仁济医院，助力免疫转化研究, objectType=article, longId=199620, objectId=730319962047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=730319962047, replyNumber=0, likeNumber=105, createdTime=2020-10-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=730319962047, moduleTitle=著名免疫学家董晨院士加盟仁济医院，助力免疫转化研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=730319962047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889434, encodeId=f5a1188943477, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Protein & Cell：揭示老年人新冠高致病率的血液免疫学基础, objectType=article, longId=199511, objectId=4bfc19951102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bfc19951102, replyNumber=0, likeNumber=86, createdTime=2021-03-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bfc19951102, moduleTitle=Protein & Cell：揭示老年人新冠高致病率的血液免疫学基础, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bfc19951102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889430, encodeId=9850188943073, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=12大方向，重点、稳定支持！NSFC生命科学部关于加强病毒学、病原微生物学和免疫学相关研究资助的通告, objectType=article, longId=190518, objectId=9829190518fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9829190518fb, replyNumber=0, likeNumber=0, createdTime=2020-12-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9829190518fb, moduleTitle=12大方向，重点、稳定支持！NSFC生命科学部关于加强病毒学、病原微生物学和免疫学相关研究资助的通告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9829190518fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889425, encodeId=e15d1889425ba, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=12个免疫学重大科学问题在京发布, objectType=article, longId=181478, objectId=727a1814e8f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=727a1814e8f6, replyNumber=0, likeNumber=93, createdTime=2020-05-27, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=727a1814e8f6, moduleTitle=12个免疫学重大科学问题在京发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=727a1814e8f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889427, encodeId=f7cc188942ee9, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Bicycle Therapeutics宣布与英国癌症研究中心合作开发新型肿瘤免疫学候选药物——多价CD137激动剂BT7401, objectType=article, longId=185937, objectId=58ff18593e64, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58ff18593e64, replyNumber=0, likeNumber=68, createdTime=2020-06-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58ff18593e64, moduleTitle=Bicycle Therapeutics宣布与英国癌症研究中心合作开发新型肿瘤免疫学候选药物——多价CD137激动剂BT7401, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58ff18593e64)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889428, encodeId=55f418894285b, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Abcam 宣布成功收购 Expedeon 的蛋白质组学和免疫学业务，进一步增强蛋白偶联技术, objectType=article, longId=186002, objectId=4bc318600231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bc318600231, replyNumber=0, likeNumber=79, createdTime=2020-09-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bc318600231, moduleTitle=Abcam 宣布成功收购 Expedeon 的蛋白质组学和免疫学业务，进一步增强蛋白偶联技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bc318600231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889424, encodeId=1aac188942419, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=J Rheumatol：50名ANCA阳性可卡因使用者的人口学、临床和免疫学相关性, objectType=article, longId=167207, objectId=ddf216e20793, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf216e20793, replyNumber=0, likeNumber=93, createdTime=2019-10-06, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf216e20793, moduleTitle=J Rheumatol：50名ANCA阳性可卡因使用者的人口学、临床和免疫学相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf216e20793)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889419, encodeId=f61f188941947, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=世界强化免疫日 | 免疫学新近进展大盘点, objectType=article, longId=155969, objectId=22e51559690f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22e51559690f, replyNumber=0, likeNumber=92, createdTime=2019-04-11, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22e51559690f, moduleTitle=世界强化免疫日 | 免疫学新近进展大盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22e51559690f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889423, encodeId=4d741889423a3, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Arthritis Rheumatol：1600个阳性样本中的冷球蛋白检测和免疫学特征, objectType=article, longId=167201, objectId=5c6716e20132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c6716e20132, replyNumber=0, likeNumber=57, createdTime=2019-07-21, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c6716e20132, moduleTitle=Arthritis Rheumatol：1600个阳性样本中的冷球蛋白检测和免疫学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c6716e20132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1889422, encodeId=424718894225d, content=<a href='/topic/show?id=f9fa290030a' target=_blank style='color:#2F92EE;'>#免疫学#</a>, objectTitle=Blood：DiGeorge综合征患者队列的临床和免疫学特征, objectType=article, longId=165004, objectId=68761650040e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68761650040e, replyNumber=0, likeNumber=92, createdTime=2019-05-14, rootId=0, userName=xiaoyeshuang, userId=6eba113, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68761650040e, moduleTitle=Blood：DiGeorge综合征患者队列的临床和免疫学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68761650040e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫学

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Nature Cancer: 肿瘤治疗加重COVID-19病情？——总结疫情下的肿瘤免疫学挑战

2021-05-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

免疫学 FRONT CELL INFECT MI 期刊投稿经验

2021-08-15

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

CELL：对儿童新冠患者的多系统炎症综合征的免疫学研究

2021-01-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

打造免疫学细胞研究”全链条”，推动“流式平台”与“单细胞平台”高效对接

2021-05-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

免疫学靶点在新冠病毒治疗中的研究进展综述

2020-07-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Nature：COVID-19的性别差异具有免疫学基础

2021-04-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

J Periodontal Res：Tregs参与了牙周炎的骨免疫学机制，有利于临床治疗决策的制定

2020-10-25

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

中国免疫学会理事长：病例锐减，新冠疫苗临床试验或移海外

2020-12-13

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

J Rheumatol：原发性干燥综合征外周神经系统受累的神经生理学特征和免疫学特征

2020-04-07

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

赛诺菲宣布将以25亿美元收购Synthorx，以增强其肿瘤免疫学业务

2020-09-02

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

著名免疫学家董晨院士加盟仁济医院，助力免疫转化研究

2020-10-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Protein & Cell：揭示老年人新冠高致病率的血液免疫学基础

2021-03-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

12大方向，重点、稳定支持！NSFC生命科学部关于加强病毒学、病原微生物学和免疫学相关研究资助的通告

2020-12-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

12个免疫学重大科学问题在京发布

2020-05-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Bicycle Therapeutics宣布与英国癌症研究中心合作开发新型肿瘤免疫学候选药物——多价CD137激动剂BT7401

2020-06-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Abcam 宣布成功收购 Expedeon 的蛋白质组学和免疫学业务，进一步增强蛋白偶联技术

2020-09-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

J Rheumatol：50名ANCA阳性可卡因使用者的人口学、临床和免疫学相关性

2019-10-06

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

世界强化免疫日 | 免疫学新近进展大盘点

2019-04-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Arthritis Rheumatol：1600个阳性样本中的冷球蛋白检测和免疫学特征

2019-07-21

xiaoyeshuang (审核中...)

前往app查看评论内容

#免疫学#

Blood：DiGeorge综合征患者队列的临床和免疫学特征

2019-05-14

科室
- - 订阅+
  - 更多科室
工具
服务